Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Diabetes Research and Clinical Practice|September 21, 2025
Association of SGLT2 inhibitors and GLP-1 receptor agonists with the risk of Parkinson's disease in patients with type 2 diabetes: A propensity score-matched cohort study with meta-analysisJia-Ai Yeh, Shu-Man Lin, Yu-Chang Liu, et al.
Scientific Reports|September 30, 2021
Evaluating the "holiday season effect" of hospital care on the risk of mortality from pulmonary embolism: a nationwide analysis in TaiwanDuan-Pei Hung, Shu-Man Lin, Peter Pin-Sung Liu, et al.
Investigative Ophthalmology & Visual Science|June 12, 2024
Use of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients With Type 2 Diabetes and the Incidence of Retinal Vein Occlusion in TaiwanHou-Ren Tsai, Yu-Jie Lin, Jih-I Yeh, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 23, 2023
Risk of serious hypoglycaemia in patients with atrial fibrillation and diabetes concurrently taking antidiabetic drugs and oral anticoagulants: a nationwide cohort studyHuei-Kai Huang, Peter Pin-Sung Liu, Shu-Man Lin, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2019
Association of Hypothyroidism and Mortality in the Elderly Population: A Systematic Review and Meta-AnalysisTou-Yuan Tsai, Yu-Kang Tu, Kashif M Munir, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 30, 2023
Association between bisphosphonate use and stroke risk: a meta-analysisShu-Man Lin, Jhe-Yi Lin, Yu-Kang Tu, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 4, 2022
Association of bisphosphonates with diabetes risk and glycemic control: a meta-analysisPo-Wei Chen, Hsiao-Yuan Su, Yu-Kang Tu, et al.
Diabetes, Obesity & Metabolism|November 3, 2020
Risk of developing diabetes in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants or warfarin: A nationwide cohort studyHuei-Kai Huang, Peter Pin-Sung Liu, Shu-Man Lin, et al.
Cardiovascular Diabetology|January 7, 2023
Risk of heart failure in elderly patients with atrial fibrillation and diabetes taking different oral anticoagulants: a nationwide cohort studyShu-Man Lin, Peter Pin-Sung Liu, Yu-Kang Tu, et al.
Annals of Internal Medicine|February 14, 2022
Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants : A Nationwide AnalysisHuei-Kai Huang, Peter Pin-Sung Liu, Shu-Man Lin, et al.
Pageof 4